CMS recently finalized the Interoperability and Prior Authorization Final Rule (CMS-0057-F). Review some of the key changes CMS made to their original proposal, how changes impact requirements for payers and providers, and how Redox can help them reach compliance.
The healthcare industry is continues to evolve, recent proposals from CMS are aimed at reducing the burden of prior authorization. As healthcare organizations work to stay compliant with the new rules, having expertise in the three leading data standards, FHIR, X12, and CDA, has become an absolute must. We take a closer look at why this expertise is crucial in ensuring compliance with the new CMS regulations.
The vaccine is coming. Unless you happen to live under a rock, you’ve noticed that much of the…
The COVID-19 crisis has thrown a harsh spotlight on flaws in America’s healthcare system. One of those flaws…
2020 has taken the healthcare industry into the depths of the Wild West. Scrambling, pistol-quick, not lawless, but…
The latest health data rules from the ONC are official. Here's what you need to know.
With the CMS and ONC final healthcare interoperability rules under review at OMB, it’s…
Getting into the Department of Health and Human Services was a bit of an adventure. Security was tight,…
This is the second part of a series about what the new CMS and ONC rules mean for…
As the largest payer in the United States, any changes proposed by the CMS that influence provider organization…
Last Monday, just as many of us were traveling to HIMSS, HHS released two long-awaited pieces of policy…